Advisory Board - Segra International
Segra International is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally.
Segra, Cannabis Micropropagation, Cannabis Tissue Culture, Research and Development, R&D, Quality Management Systems, facilities, plant-based medicines, medicinal, Cannabis, botanical, tissue culture, specialist, Genotyping Services, Tissue Culture Production, Modular Growing Facility, Micropropagation
page-template,page-template-full_width,page-template-full_width-php,page,page-id-93,ajax_fade,page_not_loaded,,footer_responsive_adv,qode-child-theme-ver-1.0.0,qode-theme-ver-10.1.1,wpb-js-composer js-comp-ver-5.0.1,vc_responsive

Advisory Board

Dave Watson

Since 1970, David Watson has traveled extensively to cannabis producing countries looking for seeds of unusual varieties, and in 1975 established Sacred Seeds, the world’s first cannabis seed company, in California. In 1986, he began Cultivator’s Choice, Amsterdam’s first cannabis seed company, breeding and introducing many foundation sinsemilla varieties still grown today. In 1992, Mr. Watson established HortaPharm BV, the world’s first established medical cannabis corporation and in 1993 he co-founded the International Hemp Association. Working under license from the Dutch Ministry of Health, HortaPharm established facilities used to breed medical cultivars and conduct cannabis research and development. Mr. Watson formulated HortaPharm’s research goals and created the team led by Dr. Etienne De Meijer that was the first to use STS as a breeding method to “self” cannabis plants and create single cannabinoid cultivars. In 1998, HortaPharm supplied varieties along with organic cultivation and integrated pest management expertise to GW Pharmaceuticals in the United Kingdom and assisted in selecting the cultivars used to produce Sativex® and other GW varieties. Mr. Watson co-authored Hemp Diseases and Pests (2000) with John McPartland and Robert Clarke, contributed to Franjo Grotenhermen’s Cannabis and Cannabinoids and Mahmoud ElSohly’s Marijuana and Cannabinoids, as well as many other articles.

Dr. Kevin Kjernisted


Dr. Kjernisted received his Medical Degree from the University of Manitoba in 1983. He worked as a general practitioner for five years before completing training to be a psychiatrist at the University of Manitoba. For more than a decade Dr. Kjernisted was Medical Director of the Anxiety Disorders Clinic and Director of Research at St. Boniface General Hospital in the Department of Psychiatry, University of Manitoba before relocating to Vancouver, where he is currently a Clinical Associate Professor of Psychiatry in the Faculty of Medicine at the University of British Columbia. Dr. Kjernisted has acted as principal investigator in over 35 clinical trials investigating compounds for mood disorders, anxiety disorders, schizophrenia, ADHD and weight management. His research interests also include the “mind-body connection” which involves interactions between the brain, the gut and the immune system (psychoneuroimmunology). Dr Kjernisted has lectured extensively on this topic to peers at national and international meetings. Optimal treatment in his busy clinical practice involves complementary and alternative treatments including probiotics, exercise and nutraceuticals, along with medications and psychotherapy, in order to address excessive inflammation and oxidation which contribute to psychiatric illness, chronic pain, heart disease, liver disease, diabetes, inflammatory bowel disease, cancer and dementia.

Dr. Avid Khamenehfar

BSc, MSc, MSc, PhD, Research and Development

Ms. Khamenehfar finished her Ph.D. in August 2015 in the field of Bioanalytical Chemistry at Simon Fraser University. In her multidisciplinary areas of research, she has helped develop a novel same-single-cell analysis for multidrug resistance (MDR) using microfluidic lab-on-a-chip technology to improve drug delivery into cancer cells. Ms. Khamenehfar has an abundance of professional experience from her time performing research with Atra Pharmaceutical Co. and as a Quality Assurance/Quality Control (QA/QC) Laboratory Manager at the Polymer & Petrochemical Research Institute in Iran for four and a half years. In those years, she proved her ability as a QA/QC Manager in the management of multiple projects simultaneously and under strict time-lines. Her extracurricular activities include participation in the Society of Young Researchers in Iran to manage research projects, organize and present several chromatography training workshops, and directly assist undergraduate student’s lab work.

Barry Daniel


Mr. Daniel is a retired police chief and proven leader with extensive administrative and operational experience of more than thirty-eight years in law enforcement. A former member of the Royal Canadian Mounted Police (RCMP) for 25 years he served in a variety of positions across Canada retiring at the rank of Inspector. He was appointed Chief Constable for the Matsqui Police Department and later as the Chief Constable of the Abbotsford Police Department upon amalgamation of the two cities. Since retiring he has been involved in numerous private enterprises both nationally and internationally. He has held appointments such as: Director Canadian Association of Chiefs of Police (CACP) and Chair of the Resolutions Committee for the CACP. President of the British Columbia Association of Chiefs of Police (BCACP). President of British Columbia Association of Municipal Chiefs of Police (BCAMCP). He is a graduate of the FBI National Academy, Quantico, Virgina as well as the Executive Development Program at the Canadian Police College in Ottawa.

Armin Prahst

B.Sc., M.Sc.

Mr. Prahst is a seasoned Scientist working for over 30 years in various positions in the Food, Beverage and Natural Health Product Industry. He graduated with a M.Sc. in Food Science from the University of British Columbia in 1994 and proved to be outstanding in his field by obtaining a scholarship at the end of his B.Sc. program in 1992 at the University of Guelph, for the highest cumulative average of the 10 Food Processing classes he took. His passion is fermentation technology and food processing which he nurtured working with various companies such as Granville Island Brewing and RJ Spagnols specifically in R&D and QC Senior positions. The last 15 years he has been operating his own business, Spagomed Laboratories, focusing on developing and marketing Natural Health Products in Canada and consulting in that industry. He was one of the first individuals to successfully create a retail line of fermented and conventionally extracted botanicals in North America. The IP that he created is currently utilized by Teawolf LLC, a highly successful botanical extract company that he co-founded and helped build as Technical Director since 2009. Mr. Prahst has a wide range of practical experience ranging from the agricultural field, to the lab bench and industrial processing over to the regulatory environment in Canada and the USA. His business travels brought him to China, Ecuador, Peru, Chile, the USA and many European countries enabling him to link not only interdisciplinary fields but also intercultural ones.

Dr. Laina Geary

Ph.D., Assistant Professor, Department of Chemistry, University of Nevada

In 2005 Dr. Geary completed her B.Sc.(Hons.) at the University of Manitoba with first class honours. She stayed at the U of M to pursue a Ph.D. under the guidance of Prof. Philip Hultin. As an NSERC postgraduate scholar, she studied the behaviour of trichloroethylene derivatives under palladium-catalyzed cross-coupling conditions and developed new routes to benzofurans and indoles via Pd-catalyzed C-H functionalization and earned a Ph.D. in 2010. She then joined the research lab of Prof. Michael Krische at the University of Texas at Austin where she studied ruthenium(II)- and iridium(I) catalyzed propargylation reactions. In 2011, Dr. Geary became one of the inaugural recipients of a Banting Postdoctoral Fellowship through NSERC. Dr. Geary joined the University of Nevada, Reno in July 2014 as an assistant professor. A project of Dr. Geary’s aims to generate a wide array of aza-cannabinoids for the treatment of cancers. The cannabinoids will be synthesized from vinyl phenols and (homo)allylic amines via a tandem palladium catalyzed olefin bisfunctionalization/ intramolecular Diels-Alder reaction, thereby satisfying the requirement for easily accessible starting materials.

Dr. Edward J. Park

Ph.D., Professor, School of Mechatronics System Engineering, Simon Fraser University

A Ph.D. and M.A.Sc. graduate of the University of Toronto, Dr. Park adds years of mechatronics and automation engineering experience to Segra’s Advisory Board. Dr. Park is currently a renowned Professor of Mechatronic Systems Engineering at Simon Fraser University in British Columbia. His research interests include mechatronics, biomechatronics, biomedical technologies, wearable technologies, and biorobotics.

Jerry Kieran

Strategic Adviser

Mr. Kieran specializes in business development, strategic pricing, and go-to-market strategies in the Commercial Agriculture and cannabis industries. As the former Chief Business Development Officer for Fluence Bioengineering, a global leader in horticultural lighting solutions, he was responsible for creating and executing the business strategies that fueled Fluence’s rapid growth. In 2018, Fluence was acquired by German lighting technology group Osram Licht AG. In his concurrent role as Executive Chairman of Catalyst BC, Jerry has developed a deep understanding for the nuance of the industry and fostered relationships with top industry professionals across the entire cannabis ecosystem, from seed to sale.